# Gemcitabine and Cisplatin for Advanced or Recurrent Endometrial Cancer

> **NCT00388154** · PHASE2 · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 21 (actual)

## Conditions studied

- Endometrial Cancer

## Interventions

- **DRUG:** Gemcitabine
- **DRUG:** Cisplatin

## Key facts

- **NCT ID:** NCT00388154
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-08
- **Primary completion:** 2013-11
- **Final completion:** 2013-11
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2014-11-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00388154

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00388154, "Gemcitabine and Cisplatin for Advanced or Recurrent Endometrial Cancer". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00388154. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*